ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1300

Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematosus Using Hidden Markov Models: A Bayesian Approach

Juan Pablo Diaz-Martinez1, Kathleen Bingham2, Robin Green3, Dorcas Beaton4, Mahta Kakvan1, Lesley Ruttan3, Carmela Tartaglia5, Marvin Fritzler6, May Choi7, Jiandong Su1, Dennisse Bonilla1, Nicole Anderson1, Joan Wither1, Patricia Katz8 and Zahi Touma9, 1University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 2Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 3Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada, 4Institute for Work & Health, Toronto, Canada, 5University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, 6Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 7Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 8University of California, San Francisco, Novato, CA, 9University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network; Krembil Research Institute, Toronto, ON, Canada

Meeting: ACR Convergence 2020

Keywords: Biostatistics, Cognitive dysfunction, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Cognitive impairment (CI) is usually operationalized on the American College of Rheumatology Neuropsychological Battery (ACR-NB) as a z-score of ≤-1.5 on ≥2 domains or z ≤-2 on ≥1 domain.

Given that this binary classification may miss participants who have CI but score just below the cut-off, we explored using continuous z-scores, instead of the binary approach of the ACR-NB, to facilitate the interpretability of the results. This framework is developed based on Hidden Markov Models (HMMs) and on existing data over time.

Methods: 301 consecutive consenting SLE patients aged 18-65 years attending a single center were assessed for CI at baseline using the ACR-NB and 187 patients completed visits at 6 and 12 months.

ACR-NB includes 19 tests and 6 cognitive domains. Age and gender matched normative data were used to obtain z-scores.

The 1st step of our approach reduces the high-dimensional aspect of the ACR-NB tests using principal component analysis (PCA) to create a single component score which explains the most variance (1st dimension). The 2nd step builds a 2-state cognitive status based on a discrete-time HMM with the dimensionality reduction gained in the first step. The HMM assumes that the change of the component score over time in patients with SLE can be segmented into 2 distinct cognitive states, where each state captures if a patient is CI or not at time t, using the component score obtained at each time point. We assumed that the component score is Normal with unknown mean and variance, and the mean and variance are different between the two hidden states (CI or non-CI). Additionally, we specified that the mean of the Normal outcome depends linearly on education level; this adjustment means that the hidden states will capture the unobserved heterogeneity not explained after controlling by education level. All the statistical analysis was done from a Bayesian perspective using Stan through R which implements the Hamiltonian Markov Chain Monte Carlo method.

Results: Of 301 patients, 89.0% were women, mean age 40.9 ± 12.1 and mean disease duration 14 ± 10.1 years at study entry. Figure 1 shows the results of the PCA; at baseline, 1st dimension separates patients into CI and non-CI and 2nd dimension was mainly explained by measures of simple information processing or motor speed.

From the HMM analysis, the estimated mean for the CI state was -1.78 (95% Credible Interval [Crl]: -4.47, 0.91) and 1.78 (95% CrI: -0.92, 4.46) for the non-CI state. A patient will be classified as CI if their observed component score lies on the area of mu[1] (Fig. 2) and as non-CI if it lies on the area of mu[2].

We found higher education level associates with an increase mean component score (implies less CI). We also found that patients did not transition between CI and non-CI over time (Fig. 3).

Conclusion: This is the first framework which aimed to classify patients with SLE as CI or not using an unsupervised method. This approach relies on the observed z-scores from the 19 tests on the ACR-NB and not on the binary classification. We found that the probability of changing between CI and non-CI over 1 year is low.

Figure 1. Biplot at baseline. PCA where patients’ component scores are colored by ACR-NB CI binary definition (turquoise for CI and orange for non-CI). The 1st dimension separates patients into CI and non-CI at baseline. Axis x represents the first dimension (explaining 28.3% of the variance) and axis y represents the second dimension. The length of each arrow represents the strength of the relationship between the ACR-NB subtests, and the cognitive components found in our PCA. The angle between variables represents the strength of the correlation between them. The ACR-NB included the following domains: Manual motor speed and dexterity, simple attention and processing speed, visual-spatial construction, verbal fluency, learning and memory, executive function.

Figure 2. Posterior estimates from the HMM. X axis represents the distribution of the parameters of interest. Y axis represents the parameters where inference is made. The dark shaded region represents the point estimate from a frequentist point of view and the light shaded region represents the 95% uncertainty interval, i.e., with 95% of probability the estimate would lie in that region. As an example mu[1] represents the inference made on the unknown mean of the observed component score given that it comes from the CI state after adjusting for education level. The point estimate is -1.78 with 95 % CrI (-4.47, 0.91).

Figure 3. Posterior uncertainty intervals for the transition probabilities in the HMM. X axis represents the transition probability and Y axis represents the parameters where inference is made. We labeled ‘1’ as the CI state and ‘2’ as the non-CI. Therefore, over discrete time points, P11 is the probability of remaining in the CI state, P12 is the probability of moving from the CI state to non-CI state and so on (P21 and P22). The dot on the graph represents the point estimate and the line represents the 95% CrI.


Disclosure: J. Diaz-Martinez, None; K. Bingham, None; R. Green, None; D. Beaton, None; M. Kakvan, None; L. Ruttan, None; C. Tartaglia, None; M. Fritzler, Inova Diagnostics Inc, 5, 8, Werfen International, 5, 8; M. Choi, None; J. Su, None; D. Bonilla, None; N. Anderson, None; J. Wither, None; P. Katz, None; Z. Touma, None.

To cite this abstract in AMA style:

Diaz-Martinez J, Bingham K, Green R, Beaton D, Kakvan M, Ruttan L, Tartaglia C, Fritzler M, Choi M, Su J, Bonilla D, Anderson N, Wither J, Katz P, Touma Z. Identifying Cognitive Impairment in Patients with Systemic Lupus Erythematosus Using Hidden Markov Models: A Bayesian Approach [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/identifying-cognitive-impairment-in-patients-with-systemic-lupus-erythematosus-using-hidden-markov-models-a-bayesian-approach/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-cognitive-impairment-in-patients-with-systemic-lupus-erythematosus-using-hidden-markov-models-a-bayesian-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology